[HTML][HTML] Direct oral anticoagulants for the treatment of cerebral venous thrombosis–a protocol of an international phase IV study
A van de Munckhof, M Sánchez van Kammen… - Frontiers in …, 2023 - frontiersin.org
Introduction Current guidelines recommend that patients with cerebral venous thrombosis
(CVT) should be treated with vitamin K antagonists (VKAs) for 3–12 months. Direct oral …
(CVT) should be treated with vitamin K antagonists (VKAs) for 3–12 months. Direct oral …
Direct oral anticoagulants for the treatment of cerebral venous thrombosis-a protocol of an international phase IV study
A van de Munckhof, MS van Kammen… - Frontiers in …, 2023 - researchportal.helsinki.fi
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an
international phase IV study — University of Helsinki Skip to main navigation Skip to search …
international phase IV study — University of Helsinki Skip to main navigation Skip to search …
Direct oral anticoagulants for the treatment of cerebral venous thrombosis–a protocol of an international phase IV study
A van de Munckhof, MS van Kammen… - Frontiers in …, 2023 - scholars.aku.edu
Introduction: Current guidelines recommend that patients with cerebral venous thrombosis
(CVT) should be treated with vitamin K antagonists (VKAs) for 3–12 months. Direct oral …
(CVT) should be treated with vitamin K antagonists (VKAs) for 3–12 months. Direct oral …
Direct oral anticoagulants for the treatment of cerebral venous thrombosis-a protocol of an international phase IV study.
A van de Munckhof, M Sánchez van Kammen… - Frontiers in …, 2023 - boris.unibe.ch
INTRODUCTION Current guidelines recommend that patients with cerebral venous
thrombosis (CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months …
thrombosis (CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months …
[PDF][PDF] Direct oral anticoagulants for the treatment of cerebral venous thrombosis–a protocol of an international phase IV study
MM Gabriel, L Palaiodimou, JM Coutinho… - 2023 - helda.helsinki.fi
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an
international phase IV study DOAC- Page 1 https://helda.helsinki.fi Direct oral …
international phase IV study DOAC- Page 1 https://helda.helsinki.fi Direct oral …
[HTML][HTML] Direct oral anticoagulants for the treatment of cerebral venous thrombosis–a protocol of an international phase IV study
A van de Munckhof, MS van Kammen… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods DOAC-CVT is an international, prospective, observational cohort study comparing
DOACs to VKAs for the prevention of recurrent venous thrombotic events after acute CVT …
DOACs to VKAs for the prevention of recurrent venous thrombotic events after acute CVT …
[PDF][PDF] Direct oral anticoagulants for the treatment of cerebral venous thrombosis-a protocol of an international phase IV study.
A Munckhof, M Sanchez van Kammen, K Krzywicka… - 2023 - repository.ubn.ru.nl
INTRODUCTION: Current guidelines recommend that patients with cerebral venous
thrombosis (CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months …
thrombosis (CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months …
Direct oral anticoagulants for the treatment of cerebral venous thrombosis-a protocol of an international phase IV study
A van de Munckhof, M van Kammen… - FRONTIERS IN …, 2023 - avesis.istanbul.edu.tr
Introduction: Current guidelines recommend that patients with cerebral venous thrombosis
(CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months. Direct oral …
(CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months. Direct oral …
[PDF][PDF] Direct oral anticoagulants for the treatment of cerebral venous thrombosis–a protocol of an international phase IV study
MM Gabriel, L Palaiodimou, JM Coutinho… - 2023 - core.ac.uk
Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an
international phase IV study Page 1 Frontiers in Neurology 01 frontiersin.org Direct oral …
international phase IV study Page 1 Frontiers in Neurology 01 frontiersin.org Direct oral …
Direct oral anticoagulants for the treatment of cerebral venous thrombosis-a protocol of an international phase IV study
A Munckhof, MS Kammen, K Krzywicka… - Frontiers in …, 2023 - ecommons.aku.edu
Introduction: Current guidelines recommend that patients with cerebral venous thrombosis
(CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months. Direct oral …
(CVT) should be treated with vitamin K antagonists (VKAs) for 3-12 months. Direct oral …